Mann WA - Search Results

1

Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes.

Evans D, de Heer J, Hagemann C, Wendt D, Wolf A, Beisiegel U, Mann WA. Evans D, et al. Among authors: mann wa. Exp Clin Endocrinol Diabetes. 2001;109(3):151-4. doi: 10.1055/s-2001-14838. Exp Clin Endocrinol Diabetes. 2001. PMID: 11409297

2

Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity.

Evans D, Mann WA, de Heer J, Michel U, Wendt D, Kortner B, Wolf A, Beisiegel U. Evans D, et al. Among authors: mann wa. Int J Obes Relat Metab Disord. 2000 May;24(5):647-51. doi: 10.1038/sj.ijo.0801214. Int J Obes Relat Metab Disord. 2000. PMID: 10849589

3

A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus.

Evans D, Aberle J, Wendt D, Wolf A, Beisiegel U, Mann WA. Evans D, et al. Among authors: mann wa. J Mol Med (Berl). 2001 May;79(4):198-204. doi: 10.1007/s001090100189. J Mol Med (Berl). 2001. PMID: 11409711

4

Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.

Brümmer D, Evans D, Berg D, Greten H, Beisiegel U, Mann WA. Brümmer D, et al. Among authors: mann wa. J Mol Med (Berl). 1998 Apr;76(5):355-64. doi: 10.1007/s001090050227. J Mol Med (Berl). 1998. PMID: 9587070

5

Frequency of and interaction between polymorphisms in the beta3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans.

Evans D, Minouchehr S, Hagemann G, Mann WA, Wendt D, Wolf A, Beisiegel U. Evans D, et al. Among authors: mann wa. Int J Obes Relat Metab Disord. 2000 Oct;24(10):1239-45. doi: 10.1038/sj.ijo.0801402. Int J Obes Relat Metab Disord. 2000. PMID: 11093283

6

Apolipoprotein E isoforms and rare mutations: parallel reduction in binding to cells and to heparin reflects severity of associated type III hyperlipoproteinemia.

Mann WA, Meyer N, Weber W, Meyer S, Greten H, Beisiegel U. Mann WA, et al. J Lipid Res. 1995 Mar;36(3):517-25. J Lipid Res. 1995. PMID: 7775863 Free article.

7

Apolipoprotein E and lipoprotein lipase co-ordinately enhance binding and uptake of chylomicrons by human hepatocytes.

Mann WA, Meyer N, Weber W, Rinninger F, Greten H, Beisiegel U. Mann WA, et al. Eur J Clin Invest. 1995 Nov;25(11):880-2. doi: 10.1111/j.1365-2362.1995.tb01700.x. Eur J Clin Invest. 1995. PMID: 8582456

8

Lipoprotein lipase compensates for the defective function of apo E variants in vitro by interacting with proteoglycans and lipoprotein receptors.

Mann WA, Meyer N, Berg D, Greten H, Beisiegel U. Mann WA, et al. Atherosclerosis. 1999 Jul;145(1):61-9. doi: 10.1016/s0021-9150(99)00015-5. Atherosclerosis. 1999. PMID: 10428296

9

Lipoprotein lipase mediates an increase in the selective uptake of high density lipoprotein-associated cholesteryl esters by hepatic cells in culture.

Rinninger F, Kaiser T, Mann WA, Meyer N, Greten H, Beisiegel U. Rinninger F, et al. Among authors: mann wa. J Lipid Res. 1998 Jul;39(7):1335-48. J Lipid Res. 1998. PMID: 9684736 Free article.

10

Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the apolipoprotein A5 gene.

Evans D, Bode A, von der Lippe G, Beil FU, Mann WA. Evans D, et al. Among authors: mann wa. Eur J Med Res. 2011 Feb 24;16(2):79-84. doi: 10.1186/2047-783x-16-2-79. Eur J Med Res. 2011. PMID: 21463987 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters